Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03784716 · ClinicalTrials.gov registry record · NA
Ketogenic Diet in Non-alcoholic Fatty Liver Disease
A NA study, sponsored by Marc Goodman.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03784716: Completed NA study, sponsored by Marc Goodman.
NCT03784716 is a NA study that has completed, run by Marc Goodman. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03784716, a NA study, has completed, sponsored by Marc Goodman.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this randomized trial is to examine the effects of a ketogenic diet on non-alcoholic fatty liver disease (NAFLD). Twenty-four participants with NAFLD will be randomized to receive a ketogenic meal plan or control (standard weight loss meal plan). Participants will be followed up to 28 days after initiation of the diet intervention.
Primary Outcome
The MRI-PDFF is a quantitative imaging test that exploits the differences in resonance frequencies between
Interventions
- OTHER Ketogenic Diet
- OTHER Standard Weight Loss Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-03-13 |
| Est. Completion | 2022-02-10 |
| Phase | NA |
What the finished NCT03784716 record still lists
NCT03784716 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Ketogenic Diet is the first listed.
NCT03784716 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03784716 about?
NCT03784716 is a clinical study titled "Ketogenic Diet in Non-alcoholic Fatty Liver Disease". The purpose of this randomized trial is to examine the effects of a ketogenic diet on non-alcoholic fatty liver disease (NAFLD). Twenty-four participants with NAFLD will be randomized to receive a ketogenic meal plan or control (standard weight loss meal plan). Participants will be followed up to 28...
What is the current status of trial NCT03784716?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2019-03-13. Estimated completion is 2022-02-10.
What interventions are being tested in trial NCT03784716?
The interventions under investigation include: Ketogenic Diet (OTHER), Standard Weight Loss Diet (OTHER).
Who is sponsoring clinical trial NCT03784716?
This trial is sponsored by Marc Goodman, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03784716's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI